CoChat

Antifungal activity of probiotic strain Lactiplantibacillus plantarum MYSN7 against Trichophyton tonsurans

Open access
Vanitha, P. R., Somashekaraiah, Rakesh, Divyashree, S., Pan, Indranil, Sreenivasa, M. Y. · 2023 · Frontiers in Microbiology

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

The primary objective of this study was to assess the probiotic attributes and antifungal activity of lactic acid bacteria (LAB) against the fungus, Trichophyton tonsurans . Among the 20 isolates screened for their antifungal attributes, isolate MYSN7 showed strong antifungal activity and was selected for further analysis. The isolate MYSN7 exhibited potential probiotic characteristics, having 75 and 70% survival percentages in pH3 and pH2, respectively, 68.73% tolerance to bile, a moderate cell surface hydrophobicity of 48.87%, and an auto-aggregation percentage of 80.62%. The cell-free supernatant (CFS) of MYSN7 also showed effective antibacterial activity against common pathogens. Furthermore, the isolate MYSN7 was identified as Lactiplantibacillus plantarum by 16S rRNA sequencing. Both L. plantarum MYSN7 and its CFS exhibited significant anti- Trichophyton activity in which the biomass of the fungal pathogen was negligible after 14 days of incubation with the active cells of probiotic culture (10 6 CFU/ml) and at 6% concentration of the CFS. In addition, the CFS inhibited the germination of conidia even after 72 h of incubation. The minimum inhibitory concentration of the lyophilized crude extract of the CFS was observed to be 8 mg/ml. Preliminary characterization of the CFS showed that the active component would be organic acids in nature responsible for antifungal activity. Organic acid profiling of the CFS using LC-MS revealed that it was a mixture of 11 different acids, and among these, succinic acid (9,793.60 μg/ml) and lactic acid (2,077.86 μg/ml) were predominant. Additionally, a scanning electron microscopic study revealed that CFS disrupted fungal hyphal structure significantly, which showed scanty branching and bulged terminus. The study indicates the potential of L. plantarum MYSN7 and its CFS to control the growth of T. tonsurans . Furthermore, in vivo studies need to be conducted to explore its possible applications on skin infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2023.1192449

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Agar overlay plates showing the growth inhibition of T. tonsurans in the presence of probiotic isolates. (a) Control plate of T. tonsurans. (b) Antifungal activity of MYSN7. (c) Antifungal activity of MYSN6. (d) Antifungal activity of MYSY1.
Figure 1 Agar overlay plates showing the growth inhibition of T. tonsurans in the presence of probiotic isolates. (a) Control plate of T. tonsurans. (b) Antifungal activity of MYSN7. (c) Antifungal activity of MYSN6. (d) Antifungal activity of MYSY1.CC BY · PubMed Central
Figure 2 Molecular characterization and phylogenetic analysis of MYSN7. Phylogenetic tree showing the relationship between different Lactobacillus spp. The dendrogram was constructed based on the neighbor-joining method.
Figure 2 Molecular characterization and phylogenetic analysis of MYSN7. Phylogenetic tree showing the relationship between different Lactobacillus spp. The dendrogram was constructed based on the neighbor-joining method.CC BY · PubMed Central
Figure 3 Probiotic properties of LpMYSN7. (A) Survival percentage of the isolate at pH2 and pH3. (B) Survival percentage of the isolate in the presence of 0.3% ox gall. (C) Antibacterial activity of LpMYSN7 CFS against the common pathogens. (D) Growth curve of LpMYSN7 with logarithmic growth phase from 4 to 14 h. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (p < 0.0001).
Figure 3 Probiotic properties of LpMYSN7. (A) Survival percentage of the isolate at pH2 and pH3. (B) Survival percentage of the isolate in the presence of 0.3% ox gall. (C) Antibacterial activity of LpMYSN7 CFS against the common pathogens. (D) Growth curve of LpMYSN7 with logarithmic growth phase from 4 to 14 h. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (p < 0.0001).CC BY · PubMed Central
Figure 4 Antibiotic sensitivity pattern of LpMYSN7. (a) Control plate. (b) ZOI for ampicillin and gentamycin. (c) ZOI for kanamycin, tylosine, and clindamycin. (d) ZOI for tetracycline, erythromycin, chloramphenicol, and streptomycin.
Figure 4 Antibiotic sensitivity pattern of LpMYSN7. (a) Control plate. (b) ZOI for ampicillin and gentamycin. (c) ZOI for kanamycin, tylosine, and clindamycin. (d) ZOI for tetracycline, erythromycin, chloramphenicol, and streptomycin.CC BY · PubMed Central
Figure 5 Growth rate of T. tonsurans with and without LpMYSN7 at different time intervals: 3, 7, 10, and 14 days of incubation. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (p < 0.0001).
Figure 5 Growth rate of T. tonsurans with and without LpMYSN7 at different time intervals: 3, 7, 10, and 14 days of incubation. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (p < 0.0001).CC BY · PubMed Central
Figure 6 Co-inoculation of LpMYSN7 with Trichophyton tonsurans spores. (A) Growth of T. tonsurans (control) showing a dense mycelial mat after 14 days of incubation. (B) T. tonsurans showing no significant increase in growth when inoculated with LpMYSN7.
Figure 6 Co-inoculation of LpMYSN7 with Trichophyton tonsurans spores. (A) Growth of T. tonsurans (control) showing a dense mycelial mat after 14 days of incubation. (B) T. tonsurans showing no significant increase in growth when inoculated with LpMYSN7.CC BY · PubMed Central
Figure 7 Biomass inhibition of Trichophyton tonsurans after 10 days of incubation in the presence of different concentrations (2%, 4%, 6%, 8%, and 10%) of sterile CFS-LpMYSN7 compared with the positive control. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (*p < 0.05; **p < 0.01; ***p < 0.001).
Figure 7 Biomass inhibition of Trichophyton tonsurans after 10 days of incubation in the presence of different concentrations (2%, 4%, 6%, 8%, and 10%) of sterile CFS-LpMYSN7 compared with the positive control. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (*p < 0.05; **p < 0.01; ***p < 0.001).CC BY · PubMed Central
Figure 8 Effect of CFS-LpMYS7 on the conidial germination of the fungal pathogen. (A) Control—Conidia of T. tonsurans showing germination at 2, 8, 16, 24, and 72 h. (B) Conidia treated with CFS-LpMYSN7 showing retarded germination at the same time intervals.
Figure 8 Effect of CFS-LpMYS7 on the conidial germination of the fungal pathogen. (A) Control—Conidia of T. tonsurans showing germination at 2, 8, 16, 24, and 72 h. (B) Conidia treated with CFS-LpMYSN7 showing retarded germination at the same time intervals.CC BY · PubMed Central
Figure 9 Percentage of conidial germination of T. tonsurans control and the conidia treated with CFS-LpMYS7 at different time intervals of 2, 4, 8, 16, 24, 48, and 72 h. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (p < 0.0001).
Figure 9 Percentage of conidial germination of T. tonsurans control and the conidia treated with CFS-LpMYS7 at different time intervals of 2, 4, 8, 16, 24, 48, and 72 h. Data shown are mean ± SE of triplicate values of independent experiments and differ significantly (p < 0.0001).CC BY · PubMed Central
Figure 10 Inhibition of T. tonsurans in different concentrations of lyophilized CFS-LpMYSN7 and ketoconazole. Data shown are mean ± SE of triplicate values of individual experiments and differ significantly (p < 0.0001).
Figure 10 Inhibition of T. tonsurans in different concentrations of lyophilized CFS-LpMYSN7 and ketoconazole. Data shown are mean ± SE of triplicate values of individual experiments and differ significantly (p < 0.0001).CC BY · PubMed Central
Figure 11 Antifungal activity of the treated CFS-LpMYSN7 against T. tonsurans. (A) Control well with SDB inoculated with the pathogen. (B) Heat-treated CFS + Pathogen showing no growth. (C) Neutralized CFS + Pathogen. (D) Proteinase-K-treated CFS + Pathogen. (E) Frozen and thawed CFS + Pathogen. (F) Long-term-stored CFS + Pathogen.
Figure 11 Antifungal activity of the treated CFS-LpMYSN7 against T. tonsurans. (A) Control well with SDB inoculated with the pathogen. (B) Heat-treated CFS + Pathogen showing no growth. (C) Neutralized CFS + Pathogen. (D) Proteinase-K-treated CFS + Pathogen. (E) Frozen and thawed CFS + Pathogen. (F) Long-term-stored CFS + Pathogen.CC BY · PubMed Central
Figure 12 Scanning electron micrographs of T. tonsurans. (a) Control—profusely branched hyphae. (b–d) Scanty branching and twisting of the hyphae, disruption in the cell wall, and a bulged terminus.
Figure 12 Scanning electron micrographs of T. tonsurans. (a) Control—profusely branched hyphae. (b–d) Scanty branching and twisting of the hyphae, disruption in the cell wall, and a bulged terminus.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. Ajah, 2016, In vitro and in vivo studies on the antifungal activity of probiotics and seaweed extract (Ascophyllum nodosum), Int. J. Innov. Sci. Eng. Technol., 3, 306
  2. Angeles, 2019, Probiotic Treatment of Skin Diseases, Disorders, and Infections: Formulations, Methods and Systems
  3. Bernard, 2017, Treatment of Greasy Skin With a Bacterial Lystate, 2
  4. 2014, Clinical and Laboratory Standards Institute, M100-S24 Performance Standards for Antimicrobial Susceptibipity Testing; 24th Informational Supplement

Cited by

See all 22

Metadata

Authors
Vanitha, P. R., Somashekaraiah, R., Divyashree, S., Pan, I., & Sreenivasa, M. Y.
Affiliations
  • University of Mysore (IN)
  • Vellore Institute of Technology University (IN)
Corresponding author
Sreenivasa, M. Y.
Venue
Frontiers in Microbiology
Published
2023-06-14
Volume
14
Pages
1192449-1192449
ISSN
1664-302X (ISSN-L)
OpenAlex
W4380683010
Cited by
22
References
69
Citations by year
2026: 7 · 2025: 5 · 2024: 8 · 2023: 2
FWCI
3.17
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Indian Council of Agricultural Research
  • University of Mysore
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Essential Oils and Antimicrobial Activity
  • Health Sciences › Medicine › Dermatology › Nail Diseases and Treatments
Keywords
Lactobacillus plantarum, Trichophyton tonsurans, antifungal activity, probiotics, lactic acid bacteria, cell-free supernatant, organic acids, succinic acid, lactic acid, conidial germination inhibition, skin infections, bile tolerance, self-aggregation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.